Targeted Strategies for Today's Evolving Markets

MissionIR Blog

MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Harnessing the Power of Artificial Intelligence to Improve Clinical Outcomes

Predictive Oncology (NASDAQ: POAI), a knowledge-driven, precision-medicine company, applies its smart tumor profiling and artificial intelligence (“AI”) platform to extensive genomic and biomarker patient data sets to predict and improve clinical outcomes for cancer patients. An article discussing the company reads, “While precision medicine, sometimes referred to as personalized medicine, is a relatively new term, the idea has been around for years (http://ibn.fm/KlNJH). Defined by the U.S. National Library of Medicine as ‘an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person,’ the approach is gaining momentum as data sets especially in genomics have grown rapidly. Applying AI approaches to these large data sets offers the ability to more deeply analyze these data much faster and with more accurate results than previously. . . .Predictive Oncology is at the forefront of this growing trend that examines multiple factors about the patient from genomics, tumor profiles, nutrition, environmental factors, lifestyle and habits to determine a plan of action for treatment. In a recent overview (http://ibn.fm/pYVQI), POAI notes that for years, big pharma has invested tremendous resources — both financial and human — in genomics in order to understand a patient’s genome and hopefully provide more targeted treatments. However, despite the significant amount of time and money devoted to the research, success rates for such targeted therapies remain low, and adoption in clinical practice is lukewarm. It has become increasingly clear that genomics alone is not enough. . . . Enter Predictive Oncology. Competitors in the cancer field must wait at least five years to determine patient survival rates for specific treatments before they can show value in the data they have gathered. POAI, on the other hand, has vast amounts of historical data that it has been compiling for years, time-tested and proven data that can be leveraged today.”

To view the full article, visit http://ibn.fm/ZYttK

About Predictive Oncology Inc.

Predictive Oncology is an AI-driven company focused on applying artificial intelligence to personalized medicine and drug discovery. The company applies smart tumor profiling and its AI platform to extensive genomic and biomarker patient data sets to predict clinical outcomes and, most importantly, improve patient outcomes for cancer patients of today and tomorrow. Predictive Oncology currently has approximately 150,000 clinically validated cases on its molecular information platform, with more than 38,000 specific to ovarian cancer. The company’s data is highly differentiated, having both drug-response data and access to historical outcome data from patients. Predictive Oncology intends to generate additional sequence data from these tumor samples to deliver on the clear, unmet market need across the pharmaceutical industry for a multi-omic approach to new-drug development. For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Predictive Oncology Inc. POAI | Leave a comment

ChineseInvestors.com Inc. (CIIX) to Focus on Core Business, Hemp-Infused/CBD Products in 2020

  • CIIX will diversify revenue streams to investor relations, marketing/sales of hemp-infused/CBD products in China and the United States
  • Company plans launch of hemp-infused wrinkle cream in China, entering potential market of nearly 1.4 billion people
  • In Q1 FY2020, CIIX sales jumped 174.7 percent to $1,956,960 from prior year; hemp/CBD products rose 569.2 percent

ChineseInvestors.com Inc. (OTCQB: CIIX), a leading financial information website for Chinese-speaking investors in the United States and China, plans to diversify revenue streams in FY2020. In a letter to shareholders, CIIX CEO Warren Wang outlined the company’s plans to focus on its core investor-relations business as well as continue to expand and market its industrial hemp-infused/CBD products in China and the United States as it eyes greater revenues and profits (http://ibn.fm/mGUbP).

In the letter, Wang said that CIIX plans to launch a hemp-infused wrinkle cream cosmetic in China in the near future. He emphasized that the focus of the company’s efforts in industrial hemp/CBD would be in China through its subsidiary CBD Biotech Co. Ltd. CIIX has supported its industrial hemp/CBD product lines in China evidenced by new product launches and initiatives taken to expand geographically in the Asian market (http://ibn.fm/emkqg).

“As product margins seem to be healthier in this market, the company’s main focus for its industrial hemp business in FY2020 will be on its China operations where we have a robust product development pipeline,” said Wang. The CIIX executive also noted that in China, industrial-hemp extract may be added to cosmetics, thus opening a potential market of nearly 1.4 billion people to the company.

Moving forward, CIIX should have an advantage in the legality/trends of industrial hemp/CBD in other Asian markets because it already has “feet on the ground” in that part of the world, explained Wang. “Although the U.S. market has experienced some favorable changes in the law related to industrial hemp/CBD, there has been some volatility, which can be a consequence of entering a nascent market,” he said. Consequently, Wang said that CIIX would invest “conservatively” in its United States hemp/CBD operation, focusing on organic growth.

Wang also disclosed in the letter that CIIX is in the process of establishing a “working cooperation” with a private equity firm in China. “We would expect this relationship to have a positive impact on our investor relations business globally,” he noted.

In its 8-K filing to the SEC, CIIX reported sharply higher revenues for Q1 2020, the three months ended August 31, 2019. Sales jumped to $1,956,960, 174.7 percent higher than the $712,360 reported for the same quarter the prior year. Hemp- and CBD-product revenues drove that increase with a contribution of $948,751 for the quarter, a 569.2 percent rise from the $141,764 in Q1 2019 (http://ibn.fm/QjZSW).

CIIX’s core investor-relations business generated $821,361 in Q1 2020, a 200 percent improvement over the $271,248 reported the same period the prior year. CIIX has refocused and grown its core business.

The Q1 2020 performance continued growth reported earlier as CIIX recorded sharp gains of 175 percent year-over-year for its FY2019, ended in May 2019. That rise was generated by FY2019 sales of $6,476,442 compared to $2,353,331 in FY2018, according to its 10-K SEC filing (http://ibn.fm/di0xI). The increase was driven by industrial-hemp and CBD-liquor product sales of $4,189,935 in FY2019 compared to $378,984 in FY2018 (http://ibn.fm/l8Fl1). Investor relations, a core business, generated gains as well. Its sales were $1,336,402 in FY2019 compared to $968,282 the prior year.

CIIX offers its audience of Chinese-speaking investors real-time market commentary, analysis and educational-related services in Chinese character language sets.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Chineseinvestors.com, Inc. CIIX | Leave a comment

MissionIRNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Releases Q3 2019 Results

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organic cannabis, on Thursday released its financial and operational results for the three and nine months ended September 30, 2019. The company’s filings are available for review via its SEDAR profile at www.sedar.com. “Q3 marked TGOD’s entry into the recreational cannabis market with a small pilot in Ontario. We were thrilled to witness such positive feedback on product quality and packaging from retailers and consumers across the province.  Based on the initial response, demand for high-quality flower is strong and TGOD is well positioned to capture the premium organic segment which is significantly underserved,” TGOD CEO Brian Athaide said in the news release. “Despite the challenging market conditions in Canada, TGOD has an opportunity to be one of the first cash flow positive cannabis companies as early as Q2 2020. We rightsized our production and our first hybrid greenhouse is being commissioned, allowing us to produce at optimal levels while avoiding excess inventory or incurring unnecessarily high operating expenses.  Our first harvest from the Ancaster hybrid greenhouse is expected in December, which will enhance our current product line and enable TGOD’s first material revenues in Canada in Q1 2020 which is very exciting.”

To view the full press release, visit http://ibn.fm/NhF3V

About The Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (US-OTC: TGODF) is a premium, global, organic-cannabis company focused on the health and wellness market. Its certified-organic cannabis is grown in living soil, as nature intended. The company is committed to cultivating a better tomorrow by producing its products responsibly, with less waste and impact on the environment. Its two Canadian facilities are built to LEED certification standards and its products are sold in recyclable packaging. In Canada, TGOD plans to expand its product portfolio by launching a series of next-generation cannabis products such as organic teas, infusers and vapes. Through its European subsidiary, HemPoland, the company also distributes premium hemp CBD oil in Europe. By leveraging science and technology, TGOD harnesses the power of nature from seed to sale. For more information, visit the company’s website at www.TGOD.ca.

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://ibn.fm/TGODF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, The Green Organic Dutchman Holdings Ltd. TGODF | Leave a comment

MissionIRNewsBreaks – Sigma Labs, Inc. (NASDAQ: SGLB) Posts Q3 2019 Financial Results

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, on Thursday reported its financial and operational results for the third quarter ended September 30, 2019. Among other highlights, the company reported revenue for the third quarter of $171,003, a significant increase compared to $128,593 for the same period in 2018. On Thursday, Sigma Labs Chairman and CEO John Rice and CFO Frank Orzechowski hosted a conference call to discuss the results for the third quarter. A replay of the conference call is available through November 28, 2019. To listen to the replay, dial 1-844-512-2921 for the toll-free line or 1-412-317-6671 for the international line and use the replay ID: 13695352. “The foundation building for our PrintRite3D commercial launch has largely been completed from a financial perspective in the third quarter of 2019,” Sigma Labs chief financial officer Frank Orzechowski stated in the news release. “Notable improvements to our sales infrastructure and channels have been made that resulted in several new RTE programs which can be seen in our growing inventory metric and why we thought it was important to articulate the multiple revenue opportunities currently underway with licensing partners and end-users. Moreover, in the fourth quarter, the pipeline of verbally committed and or signed purchase orders in the channel currently totals $1.2 million. I am also happy to report that we are in active negotiations with OEM partners for strategic alternatives who currently see the immense value in our enterprise and look forward to providing an update on that front as they develop.”

To view the full press release, visit http://ibn.fm/Vuwks

About Sigma Labs

Sigma Labs, Inc. (NASDAQ: SGLB) is an emerging provider of quality assurance software to the commercial 3D printing industry under the PrintRite3D® brand. Founded in 2010, Sigma is a software company that specializes in the development and commercialization of real-time computer aided inspection (“CAI”) solutions known as PrintRite3D® for 3D advanced manufacturing technologies. Sigma Labs’ advanced computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance mid-production, uniquely allowing errors to be corrected in real-time. For more information, please visit www.SigmaLabsInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://ibn.fm/SGLB

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Sigma Labs Inc. SGLB | Leave a comment

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Appoints Strategic Advisor, Advances Tech Platform as Alternative to Smoking and Vaping

  • Lexaria Bioscience is dedicated to providing healthful alternatives to drug-substance inhalation by providing an edible technology that works as effectively as smoking or vaping at getting substances into the bloodstream
  • The company’s DehydraTECH platform has been licensed to multiple companies in the cannabis and tobacco industries, and Canada’s recent nationwide legalization of cannabis edibles is expected to open even more of a market
  • Gregg Smith, the founder of a New York-based “culture tech” venture investment firm, has joined Lexaria as a senior advisor to help define the company’s leadership strategies

Innovations in drug delivery are making the wellness product market safer and more effective in its niche as an alternative to costly pharmaceuticals or foreign remedies that lack governmental approval. Bio-delivery technology developer Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a world leader in edible drug science to combat the ills of substances that might otherwise be inhaled into the lungs.

Lexaria’s proprietary DehydraTECH™ drug delivery platform is patented to work with existing substances such as nicotine, cannabidiol (CBD) and other non-psychoactive and psychoactive cannabinoids to get orally ingestible versions of the substances into the bloodstream at speeds comparable to inhaled products, virtually eliminating a key reason people might risk sustained injury to their lungs to use those products.

“Wherever there are many victims from past injustices, there is a lot of anger and resentment that doesn’t go away easily,” CEO Chris Bunka told Forbes in discussing Lexaria’s aim to get nicotine users to move away from “life-threatening” smoking habits to satisfy their cravings (http://ibn.fm/oMc9G). “My father also died from lung cancer just last year, so I am no fan. … The fact that (DehydraTECH) is fast means that smokers might not be frustrated waiting for their nicotine experience to begin, the way they have been with traditional nicotine products such as gums and lozenges.”

Lexaria recently announced the appointment of Gregg Smith, the founder of a New York-based “culture tech” venture investment firm, as a senior advisor in helping define Lexaria’s leadership strategies.

“I am passionate about creating a smokeless future and recognize that the consumption methods of nicotine and cannabis will change,” Smith stated in the news release (http://ibn.fm/Srpvg). “Lexaria’s technology, DehydraTECH™, will completely disrupt and improve the consumption and delivery of oral nicotine, CBD and cannabis. Lexaria’s recognition of the recent FDA recognition of certain oral delivery forms of nicotine as ‘less harmful’ to human health than combustible smoking will be a driving force of changing consumer preferences.”

One strategy Lexaria has already been pursuing includes introducing DehydraTECH-licensed products to consumers through adult-format beverages, building on a relationship with Toronto-based Hill Street Beverage Company Inc. (TSX.V: BEER), a company renowned for its alcohol-free beers and wines.

“Our alcohol-free business continues to grow as more and more people turn away from alcohol and look for better alternatives. But we’re more than just the world’s most award-winning alcohol-free beverage company,” Hill Street’s website states (http://ibn.fm/JvQRy). “We’ve licensed a technology that allows us to take that award-winning adult-beverage portfolio and infuse it with cannabis… without any impact to the smell or the taste of the product.”

Canada legalized cannabis-infused edibles and beverages in October, and the first products are expected to begin hitting store shelves soon (http://ibn.fm/80XHA).

Market analysts at Deloitte predict the Canadian market for edibles and alternative cannabis products alone will be worth $2.7 billion a year, and that cannabis extract-based products including edibles will make up nearly 60 percent of the total at $1.6 billion (http://ibn.fm/1VkfJ).

Lexaria has already licensed its technology to multiple companies in North America in the cannabis and tobacco industries. The company operates a licensed in-house research laboratory and its IP portfolio includes 16 patents granted and over 60 patents pending worldwide.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Lexaria Bioscience Corp. (LXRP) | Leave a comment

SRAX Inc.’s (NASDAQ: SRAX) BIGtoken Platform Numbers 16 Million-Plus as Consumers Respond to Opt-In Data Management

  • To date, more than 16 million consumers around the world have joined; that number increases daily
  • SRAX offers other powerful data-management tools

SRAX Inc. (NASDAQ: SRAX), a digital marketing and consumer data management technology company, has had more than 16 million consumers opt-in to its BIGtoken consumer-managed data platform since the product was released earlier this year. In addition, SRAX offers other powerful products designed to provide marketers and consumers with the tools to unlock the value of data.

During an interview at SNNLive at the Planet MicroCap Showcase 2019 in Las Vegas, SRAX CEO and co-founder Christopher Miglino was asked about the “secret sauce” to getting such a high response rate (http://ibn.fm/9L1mf). Miglino noted that the budget for the launch was $2 million, but the company started with a modest $20,000. “We spent twenty grand, and the thing went completely viral,” he said. “People started signing up all over the place. We were having around 700,000 invites a day going out through the platform, so people were inviting 700,000 a day to the platform… If you go to social media even today and you pull up Twitter and YouTube and Instagram, and type in BIGtoken, you’ll see thousands of posts, thousands of consumer engagements from people talking about how they love the platform.”

From that impressive start, BIGtoken has grown into an exclusive platform with more than 16 million opted-in consumers around the world. “BIGtoken is unique in the data set it has gathered, the way it rewards consumers who have opted in and the manner it provides access to that data to marketers,” Miglino observed. “Consumers are becoming much more aware of their own privacy. A few years ago, people didn’t care, but now all of a sudden, consumers are realizing that their data is worth a lot of money. We’re working very hard to create an environment where consumers own that data on their own, and when anybody wants to access that data, they are monetizing the issue.”

In addition to BIGtoken, SRAX provides other valuable technology tools that unlock data to reveal brands’ core consumers across marketing channels. Those tools include the following:

  • SRAX Core allows users to integrate inventory and reporting from all vendors, channels and formats in one dashboard; build and save custom data segments in seconds; and gain deep insights into campaign optimization with a dedicated single point of contact;
  • SRAX IR allows users to discover insights about their shareholders and market makers and their contributions to the company; manage and monitor ROI from investor relations firms; grow shareholder base with precise audience-building, targeting and delivery across programmatic and social channels; and save new contacts from investor events and provide them collateral within the platform;
  • SRAX Auto allows users to use first-party data to ensure their brand is top of mind when known car buyers lease again; track and target test drivers and visitors to specific dealerships; link direct-mail programs to online ad targeting; and
  • SRAX Shopper allows users to influence shoppers at the pivotal place and time with intent-based geotargeting; drive in-store foot traffic and purchases; and deliver personalized shopper-ad experiences.

Based in Los Angeles, SRAX is a digital-marketing and data-management technology company focused on building the largest and most valuable opted-in data set in the world. The company provides marketers, content owners and consumers with proprietary tools to unlock the value of that data. SRAX technology also unlocks data to reveal brands core consumers and their characteristics across marketing channels. SRAX delivers a digital competitive advantage for brands in the healthcare, CPG, automotive, sports and lifestyle verticals.

For more information, visit the company’s website at www.SRAX.com

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in SRAX, Inc. SRAX | Leave a comment

Sigma Labs Inc. (NASDAQ: SGLB) is “One to Watch”

  • Provider of revolutionary quality assurance software to the commercial 3D printing industry under the PrintRite3D® brand
  • Estimated addressable market is $1.4 billion, projected to exceed $3.9 billion by 2023
  • Currently, there are 23 Sigma Lab installations across 19 different users located around the globe
  • Evaluations are underway with Tier-1 OEM clients for potential production-level software integration
  • Experienced management team with deep industry experience, supplemented by an industry leading scientific advisory board
  • Robust patent strategy established to protect intellectual property with seven patents granted, 18 patents pending, and four patent applications pre-publication

Sigma Labs Inc. (NASDAQ: SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.

For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.

Revolutionizing Additive Manufacturing

Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.

Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.

Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.

The Challenge

Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.

Innovative Approach

Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.

Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.

Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.

Market Opportunity

Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.

Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.

Management Team

John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.

Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.

CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.

Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.

For more information, visit the company’s website at www.SigmaLabsInc.com

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://ibn.fm/SGLB

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Sigma Labs Inc. SGLB | Leave a comment

MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Reports Q2 Fiscal Year 2020 Financial Results, Provides Corporate Update

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, this morning released its financial results for the three and six months ended September 30, 2019. The company’s unaudited condensed interim consolidated financial statements for Q2 2020, as well as its management’s discussion and analysis (“MD&A”) for Q2 2020, are available under its SEDAR profile and the company’s website. “Headlined by our graduation to the TSX, our business matured during the second quarter as we launched our Strategic Advisory Board and continued to work closely with our portfolio companies as they achieved new milestones,” Canopy Rivers president and CEO Narbé Alexandrian said in the news release. “There were numerous achievements for our portfolio companies this quarter. Several of these companies received licences and amendments from Health Canada for the sale of cannabis oils, while others made key acquisitions, launched their Canadian business, or brokered agreements with companies both inside and outside of the Canopy Rivers ecosystem. As we move forward, we plan to continue to develop a robust ecosystem of mutually beneficial cannabis companies intended to drive the industry forward and lay down the foundation for long-term success.”

To view the full press release, visit http://ibn.fm/MkkoJ

About Canopy Rivers Inc.

Canopy Rivers is a venture capital firm specializing in cannabis. Its unique investment and operating platform is structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit the company’s website at www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://ibn.fm/CNPOF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Canopy Rivers Inc. CNPOF, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Enters Financing Arrangements for up to $103 Million

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organic cannabis, today announced its entry into signed arrangements for up to $103 million in funding. According to the update, the financing package consists of three elements: a definitive agreement for a sale-leaseback of the Ancaster Energy Centre; a construction mortgage loan term sheet; and a convertible equity note term sheet. “Our ability to raise capital, despite recent headwinds affecting the entire sector, is a clear show of confidence from our financial partners,” TGODF CEO Brian Athaide said in the news release. “It is reflective of the value of our significant assets, the trust investors are putting into TGODF’s strong corporate governance, transparency and accountability, and the opportunity for the company’s unique positioning to quickly capture and grow the organic segment.”

To view the full press release, visit http://ibn.fm/bJUVv

About The Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (US-OTC: TGODF) is a premium, global, organic-cannabis company focused on the health and wellness market. Its certified-organic cannabis is grown in living soil, as nature intended. The company is committed to cultivating a better tomorrow by producing its products responsibly, with less waste and impact on the environment. Its two Canadian facilities are built to LEED certification standards and its products are sold in recyclable packaging. In Canada, TGOD plans to expand its product portfolio by launching a series of next-generation cannabis products such as organic teas, infusers and vapes. Through its European subsidiary, HemPoland, the company also distributes premium hemp CBD oil in Europe. By leveraging science and technology, TGOD harnesses the power of nature from seed to sale. For more information, visit the company’s website at www.TGOD.ca.

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://ibn.fm/TGODF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, The Green Organic Dutchman Holdings Ltd. TGODF | Leave a comment

MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Reports Q3 2019 Financial Results

SRAX (NASDAQ: SRAX), a digital-marketing and consumer-data-management technology platform company, announced third quarter 2019 financial results for the three months ended September 30, 2019. Among other highlights, the company reported net income of $1.4 million for the quarter and an increase in product or “vertical” sales of 11% and 17%, respectively compared to Q2 2019 and Q3 2018. Company management discussed the results and answered questions in a conference call on November 13. To listen to a replay of the call, which will be available until November 27, dial 1-844-512-2921 for the United States/Canada line or 1-412-317-6671 for the international line and use the code 13695604. The call will also be available on SRAX’s website at for at least 90 days. “BIGtoken is expanding in reach and scope. As of today, we have a subscriber base of 16.3 million. To broaden and accommodate our international subscriber base, we signed key partnerships in India and the Philippines; completed integration for international users; and started the process to offer BIGtoken in multiple languages. Now, we are implementing more initiatives to scale subscriber growth and launch additional offerings. After unveiling BIG Rewards(TM), some of the largest consumer packaged goods (CPG) brands in the world-initiated programs to offer coupons, exclusive product deals and more. Upon introducing BIG Research to gather insights on behalf of large brands looking for global customer insights, we have signed deals with two of the largest research platforms. Additionally, after spending the past two quarters integrating our platforms and realigning the sales process, in Q4 2019, we expect to accelerate revenue growth driven by brands activating on our platforms to engage with consumers complemented by increased adoption of SRAX IR,” SRAX founder and CEO Christopher Miglino stated in the news release.

To view the full press release, visit http://ibn.fm/bv911

About SRAX Inc.

SRAX (NASDAQ: SRAX) is a digital-marketing and consumer-data-management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and the characteristics of those consumers across marketing channels. Monetizing its data sets, SRAX is growing multiple, recurring revenue streams through its various platforms. Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby offering everyone in the internet ecosystem choice, transparency and compensation. SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform. For more information, visit the company’s website at www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, SRAX, Inc. SRAX | Leave a comment